Illumina

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R. 

CEO
Jacob Thaysen
CEOJacob Thaysen
Employees
8,600
Employees8,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
8,600
Employees8,600

ILMN Key Statistics

Market cap
31.76B
Market cap31.76B
Price-Earnings ratio
34.81
Price-Earnings ratio34.81
Dividend yield
—
Dividend yield—
Average volume
2.06M
Average volume2.06M
High today
$211.88
High today$211.88
Low today
$200.79
Low today$200.79
Open price
$202.98
Open price$202.98
Volume
1.63M
Volume1.63M
52 Week high
$309.35
52 Week high$309.35
52 Week low
$112.65
52 Week low$112.65

Stock Snapshot

The current Illumina(ILMN) stock price is $209.91, with a market capitalization of 31.76B. The stock trades at a price-to-earnings (P/E) ratio of 34.81.

During the trading session on 2026-11-18, Illumina(ILMN) shares reached a daily high of $211.88 and a low of $200.79. At a current price of $209.91, the stock is +4.5% higher than the low and still -0.9% under the high.

Trading volume for Illumina(ILMN) stock has reached 1.63M, versus its average volume of 2.06M.

The stock's 52-week range extends from a low of $112.65 to a high of $309.35.

The stock's 52-week range extends from a low of $112.65 to a high of $309.35.

ILMN News

MarketWatch 2h
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Simply Wall St 19h
How Investors Are Reacting To Illumina Cybersecurity Recalls

Illumina recalled thousands of NextSeq 550Dx, MiSeq Dx and NovaSeq 6000Dx diagnostic instruments after identifying cybersecurity vulnerabilities in data communi...

How Investors Are Reacting To Illumina Cybersecurity Recalls
Simply Wall St 6d
Illumina After Its MRD Workflow Launch With Valuation Still In Focus

Why Illumina's MRD Duplex Workflow Matters For The Stock Illumina (ILMN) has put its molecular residual disease research ambitions front and center with an ear...

Illumina After Its MRD Workflow Launch With Valuation Still In Focus

Analyst ratings

43%

of 23 ratings
Buy
43.5%
Hold
39.1%
Sell
17.4%

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.